This edition features a handful of India's Most Reliable Healthcare Solution Providers 2024 that are at the forefront of leading us into a digital future
Patna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Indias Most Reliable Healthcare Solution Providers 2024.pdf
1. March | Issue 02 | 2024
www.insightscare.in
From Crisis to Opportunity
How India's Healthcare
Sector is Adapting to Change
Afser Shariff
Founder and CEO
Operon Biotech & HealthCare
Operon
Biotech and Healthcare
Cra ing a Healthier Tomorrow in India
India'sMost
Reliable
Healthcare
Solution Providers
2024
Beyond Borders
India's Healthcare Solutions
Making a Global Impact
5. he Indian healthcare sector has witnessed
Tremarkable growth in the past decade, driven by the
convergence of the latest technology, skilled
professionals, and a commitment to delivering quality care.
As the demand for healthcare services continues to rise, the
need for reliable and efficient healthcare solutions has
become increasingly important.
In 2024, the sector is set to experience a profound
transformation, driven by advancements in HealthTech.
This evolution is headed by companies that are developing
innovative solutions, delivering superior services, and
prioritizing patient care. From telemedicine platforms
connecting patients to doctors remotely, to advanced
medical devices improving diagnostic accuracy, these
providers are at the forefront of innovation and excellence.
This special edition of Insights Care India, titled ‘India's
Most Reliable Healthcare Solution Providers 2024,’
dives into the dynamic healthcare industry in India,
spotlighting the innovative and reliable healthcare solution
providers that are shaping the industry.
As India emerges as a global hub for healthcare solutions, it
is essential to recognize and celebrate the achievements of
these reliable healthcare providers who are making a
significant impact on the industry. Their dedication to
quality, reliability, and patient-centric care sets them apart
and positions India as a key player in the global healthcare
space.
Let us explore the stories and insights shared in this edition,
as we celebrate the achievements of India's most reliable
healthcare solution providers and their contributions to
shaping the future of healthcare.
Wishing you an enlightening and inspiring read!
Shaping
Healthcare
A Focus on Trust and Innovation
-Nisha Mehra
Nisha Mehra
7. Articles
Beyond Borders
India’s Healthcare Solu ons
Making a Global Impact
From Crisis to Opportunity
How India’s Healthcare
Sector is Adap ng to Change
MGM Healthcare
Empowering Healthcare
Transforma on
Redcliffe Labs
Transforming Healthcare
with Affordable &
High-Quality Diagnos c Services
Profiles
9. Brief
Featuring
Person
Company
Operon Biotech and Healthcare is recognized for
its innovative solutions and dedication to
enhancing hematology and healthcare through
the delivery of quality products and technical
support.
Redcliffe Labs is a leading provider of diagnostic
solutions in India, offering a wide range of products
and services to cater to the needs of clinical
laboratories, hospitals, and point-of-care testing.
MGM Healthcare is a healthcare solutions provider
based in India, offering a comprehensive suite of
services to cater to the needs of hospitals, clinics,
and healthcare facilities.
Scitus Healthcare Solutions is a healthcare
technology company that provides a range of
services and solutions to enhance healthcare
delivery.
Operon Biotech
& HealthCare
operonbiotech.com
Afser Shariff
Founder and CEO
Mr. Harish Manian
Group CEO
Dheeraj Jain
Founder
Yogendran Yogi
CEO
MGM Healthcare
mgmhealthcare.in
Redcliffe Labs
redcliffelabs.com
Scitus Healthcare
Solutions
scitushealthcare.com
Sun Pharmaceutical Industries Ltd is an Indian
multinational pharmaceutical company that
manufactures and sells pharmaceutical
formulations and active pharmaceutical
ingredients (APIs).
Dilip Shanghvi
Founder and
Managing Director
Sun Pharmaceutical
Industries Ltd
sunpharma.com
India'sMost
Reliable
Healthcare
Solution Providers
2024
11. Operon
Biotech and Healthcare
Cra ing a Healthier Tomorrow in India
Following a successful 9+ years
at Rapid Diagnos cs, armed with a
determina on to create something
unique, Mr Afser laid the founda on for
Operon Biotech and Healthcare in
August 2008.
‘‘ ‘
‘
12. resonates with his professional journey. Here are the
enduring values that define Mr Afser:
1. Don't stop learning: The pursuit of knowledge is a
constant, irrespective of roles or positions.
2. Take Risks: Embracing challenges and taking
calculated risks is fundamental to growth and
innovation.
3. "Try" before saying NO and do it any which way: A
proactive approach to problem-solving, where attempts
precede negations, is a key mindset.
4. Build Trust by staying True to self and others around
you: Trust is nurtured through authenticity and
integrity, both within oneself and in relationships with
others.
5. Be honest in talks, commitment, and offers:
Transparency and honesty form the foundation of
meaningful interactions and business dealings.
6. Be patient, persevere, and stay put in the process:
Long-term success requires patience, perseverance, and
commitment to the journey.
7. It's one life, take care of yourself and live to the
Potential: A holistic approach to life, emphasizing self-
care and unlocking one's full potential.
His mantra is clear: Start small but start now. This outlook
reflects the urgency to seize opportunities and capitalize on
the significant growth that India is poised to experience in
the present and the future.
Cutting-Edge Coagulation Solutions
In the field of coagulation, Operon Biotech possesses a suite
of revolutionary services and products, redefining
hemostasis with unparalleled precision and efficiency.
Here's a glimpse into Operon's groundbreaking offerings:
TM
1. FibriTimer ZETA-1
A FIRST Hemostasis System to be developed by any
TM
INDIAN COMPANY. Yes, FibriTimer is a MADE-IN-
INDIA medical device built by DBI. It is the first Indian
company to indigenously develop a Multipurpose
Hemostasis Device. The Zeta -1 is exquisitely designed,
lightweight crafted by professionals for professionals and
proudly boasts of a 3.5-inch touch capacitive screen, easy
menu options, a single use disposable cuvette to carry out
array of coagulation assays, an optional automated pipette
for accurate clot activation and an inbuilt printer helping the
user with a hardcopy printout. FibriTimer ZETA -1 is born
unconventional to bust the stereotypes.
2. Operon XL 1000i: State-of-the-Art Automation
A fully automated blood coagulation analyzer with a
compact benchtop design, capable of effortlessly
performing routine PT, PTT, Fib, and TT, accommodating
special investigations with ease.
3. Operon XL 1000e: Efficiency in Mid-Size Laboratories
Ÿ A benchtop system tailored for mid-size laboratories
handling 50-100 samples per day.
Ÿ Features a throughput of 120T/hour, 35 sample
positions, 20 reagent positions, and unique advantages
such as dual technology support, bi-directional LIS,
barcode reading, inbuilt QC records, and chromogenic
testing capabilities.
Ÿ Within 4 years of launch it touched close to 100 users in
Karnataka itself making it the biggest player in this
segment.
4. XL 3690 Floor Model: High Throughput Automation
Ÿ A 10-channel automated system with an integrated PC,
designed for high-throughput coagulation labs
processing 150 samples per day and above.
Ÿ Boasts a throughput of 600T/hour, 60 sample positions,
and reagent positions, with unique features like pre-
heated probe continuous sample loading, dual probe
technology, integrated barcode, and bidirectional LIS
support.
Be it a simple single
channel system for a
clinical lab or a self-tes ng
device for INR monitoring
to an affordable entry-
level automa on to mid-
sized automa on, we
have it all.
‘‘ ‘
‘
13. 5. QuikCoag by BioMedica Diagnostics: Comprehensive
Coagulation Solutions
Ÿ Operon Biotech represents the FDA 510(k) cleared, CE
marked, and/or Health Canada registered QuikCoag
brand in India.
Ÿ BioMedica Diagnostics develops and manufactures a
comprehensive line of reagents, kits, calibrators, and
controls for routine and specialty coagulation.
6. qLabs®: Handheld Point-of-Care Precision
Ÿ A handheld Point-of-Care device by Operon Biotech,
offering rapid testing for PT-INR and APTT using
fingerstick blood.
Ÿ Enables real-time, lab-quality results within minutes,
either at Point of Care or in the comfort of home.
Ÿ Cleared and certified for global markets by CE, TUV,
and LUMC authorities, revolutionizing coagulation
testing compared to conventional laboratory methods.
Navigating the Dynamics of India's IVD Market
The Indian In-Vitro Diagnostics (IVD) market stands robust
at a staggering 80,000 Crores (9600 million USD), with
Hemostasis carving its niche at 500 Crores (60 Million
USD) and showcasing a commendable 10-14% Compound
Annual Growth Rate (CAGR).
Within this landscape, coagulation emerges as a key pillar,
poised to be continually lead in the IVD market. The
commonly requested tests, including Prothrombin Time
(PT), Activated Partial Thromboplastin Time (APTT),
Fibrinogen (FIB), Thrombin Time (TT), and D-Dimer,
underscore the pivotal role of coagulation testing. Tertiary
care hospitals and referral labs are driving this demand,
seeking greater automation and integration, particularly for
esoteric coagulation tests like D-Dimer, Thrombotic Panel,
and APLA testing.
Coagulation tests serve critical purposes such as:
- Diagnosing Bleeding Disorders: Including inhibitor
screening.
- Monitoring Anticoagulant Therapies: Assessing the
effectiveness of ongoing treatments.
- Identifying Thrombo-embolic Diseases: Such as APCR
(Factor V mutation) or elevated Homocysteine levels.
- Pre-Surgery Screening: Essential for patients with
potential bleeding disorders.
14. Bioinnovations Pvt Ltd is an aspiring MedTech startup
focused on indigenous design, development and
manufacturing of medical devices that would effectively
address the pain-points of rural labs with customized
solutions.
Specializing in the field of Hemostasis (Coagulation),
Operon Biotech and Healthcare proudly identifies itself as
"Composite Coagulation Experts," constantly striving to
add business value to this critical domain.
Operon biotech's strength lies in its exclusive product
range, reputable customer base and its commitment to the
customers to ensuring accurate results every time.
Empowered by a dedicated team, profound industry
knowledge, and a strong customer network, the company is
steadily expanding its footprint across the vast expanse of
the country, solidifying its presence through a network of
distributor partners and satisfied customers alike.
In an exclusive interview with Mr Afser, we dive into the
captivating journey that led to the creation of one of India's
most trusted healthcare solution providers.
Join us as we uncover the vision, dedication, and
innovation driving Operon Biotech and Healthcare towards
a brighter, healthier future for all.
The landscape of healthcare is ever-evolving, with
innovation and patient-centric solutions as
keystones. has
Operon Biotech and Healthcare
established itself as an institution of relentless commitment
in this dynamic domain. Situated in the vibrant setting of
Bangalore, Karnataka, this professionally managed
biomedical powerhouse is rewriting the healthcare narrative
in India.
Led by the visionary Afser Shariff, a leading figure in the
field of IVD - Medical Devices, Operon Biotech and
Healthcare has emerged as a formidable force in the Indian
healthcare landscape. With a global outlook, the company
forges strong collaborations with some of the finest brands
worldwide, working in unison with its customers to deliver
comprehensive end-to-end solutions.
Afser is not just the Founder and CEO of Operon Biotech
and Healthcare but also the co-founder of Dfine
Bioinnovations Pvt Ltd, an aspiring MedTech startup.
While Operon Biotech and Healthcare with its 14 years of
market standing has introduced several stellar products in
Indian Medical Device Industry and continues to support
the diagnostic Labs with important testing tools sourced
across the globe that would empower them with latest in
technology and help them deliver quality reports fairly and
quickly without much burn on their pocket. While Dfine
India's Most Reliable Healthcare Solution Providers 2024
15. The Founding Story
Established in August 2008, Operon Biotech embarked on a
mission to provide stable and sustainable tools for clinical
laboratories. Its impressive product portfolio, spanning lab
diagnostics and point-of-care testing (POCT) in
coagulation, reflects a commitment to diverse and
comprehensive solutions.
"Be it a simple single channel system for a clinical lab or a
self-testing device for INR monitoring to an affordable
entry-level automation to mid-sized automation, we have it
all," proudly asserts Mr Afser.
Specializing in in-vitro diagnostic tools for clinical
laboratories, healthcare, and point-of-care testing, Operon
Biotech and Healthcare's strength lies in its robust product
line, a respected customer base, and a relentless
commitment to unparalleled customer support.
Dfine Bioinnovations Pvt Ltd (DBI), an ISO 13485-2016
and ZED-certified, CDSCO-registered MedTech Startup
based in Bangalore, India, is an integral part of this
healthcare narrative. Incubated at the prestigious FSID (An
incubation arm of IISC – Bangalore), Dfine Bio-
Innovations, with a founding team of 4 members boasting a
cumulative industry experience of over 50 years, aims to
indigenously develop cost-effective and sustainable medical
devices indigenously, maintaining high standards in design
and delivery. DBI is a proud winner of "EMERGING
SMB" by the Lenovo IT4SMB Awards 2023, Bangalore
Edition and the All India MediCALL innovation award
(finalist) held at Chennai 2023. DBI is supported by
Honeywell and Nidhi Prayas funding.
With a strong product range, an exceptional team, enviable
market standing, domain expertise, and a commitment to
continuous innovation, Operon Biotech and Healthcare has
evolved into a strong regional player, making its mark in
Karnataka. The company is resolute in replicating its
regional success across India and aims to extend its
footprint beyond the borders of Karnataka.
From Twist of Fate to Entrepreneurship
Mr Afser's entry into the IVD medical device industry was
an unexpected turn of events, a beautiful stroke of
serendipity. In the year 1998, he found himself in the field
of IVD not by choice but by a twist of fate while filling out
a credit card application form for the director of Rashmi
Diagnostics Pvt Ltd, a happening IVD company at the time.
Although the stint at Rashmi Diagnostics was brief, lasting
no more than a year, Mr Afser's trajectory continued as he
assumed the role of Marketing Manager at Rapid
Diagnostics Pvt Ltd. Here, he passionately continued his
focus on Haemostasis (Coagulation) products, contributing
significantly to market penetration and business
consolidation across India.
Rapid Diagnostics represented Sigma Diagnostics for its
Coagulation range in reagents and Amelung Gmbh for its
instrument range. In an interesting turn, Sigma Diagnostics
later acquired Amelung Gmbh, and the chain of acquisitions
eventually led to Trinity Biotech Plc, an Irish company
acquiring Sigma-Amelung brands. This sequence concluded
with a full circle, as Trinity Biotech Plc, in turn, was
acquired by the company, Diagnostica Stago, where Mr
Afser had started his professional journey.
He embarked on a new chapter after gaining profound
product knowledge and understanding specific customer
needs. Following a successful 9+ years at Rapid
Diagnostics, armed with a determination to create
something unique, Mr Afser laid the foundation for Operon
Biotech and Healthcare in August 2008. Thus, a journey
that began with a stroke of serendipity and a credit card
application form came full circle with establishing his own
venture.
Principles for Professional Excellence
For Mr Afser, whether in the capacity of an employee or as
an entrepreneur, his core beliefs and values have remained
consistent. These principles serve as the guiding light
through different roles, encapsulating a philosophy that
Operon Biotech
and Healthcare's strength
lies in its robust product
line, a respected
customer base, and a
relentless commitment to
unparalleled customer
support.
‘‘ ‘
‘
16. Ÿ Screening and Monitoring Hemophilia Patients:
Ensuring proactive healthcare for this patient
demographic.
Ÿ Monitoring Liver Functions: Especially Vit-K
dependent factors.
Ÿ Understanding Coagulopathies: Such as Disseminated
Intravascular Coagulation (DIC), Liver Disease, etc.
Challenges Faced by Indian MedTech Startups in the
Global Arena
Venturing on the journey of a MedTech startup in India, a
landscape brimming with innovation, promises, and
aspirations comes with its set of challenges. Among these, a
key hurdle standing prominently is the acute lack of
exposure to funds. This challenge, common among startups,
often becomes the decisive factor, dictating the pace of
growth and even leading to the downfall of many promising
ventures.
In the backdrop of India's historical reliance on imports,
another significant challenge surfaces – the absence of
certification and accreditation bodies equivalent to CE/FDA
standards. This absence acts as a red flag, requiring strategic
navigation for startups to establish credibility and meet
global benchmarks.
Market acceptance of "Made in India" products adds yet
another layer to the challenges. Overcoming preconceived
notions and establishing trust in the quality and innovation
of indigenous products becomes a continual uphill battle.
Further complicating the journey is the fierce competition
Operon Biotech
possesses a suite of
revolu onary services and
products, redefining
hemostasis with unparalleled
precision and efficiency.
‘‘ ‘
‘
17. posed by foreign companies. The global stage,
while ripe with opportunities, also exposes
startups to intense competition, requiring them
to showcase unique value propositions to gain
a foothold.
The tendering system in India, often perceived
as unfriendly to startups, adds to the
complexities. Negotiating this landscape
demands resilience and strategic acumen to
navigate bureaucratic processes.
Innovation Amidst Challenges
India is emerging as a promising market,
attracting homegrown startups to carve a niche
in the unfolding opportunities. It's a period of
sustained endurance through the turbulent and
evolving times – a test where the "survival of
the fittest" theory finds a perfect fit.
The Indian government actively engages with
representatives like AIMED, adopting a
favourable environment for growth. Mr Asfer
firmly believes that this juncture offers the
ideal moment for young, ambitious
entrepreneurs to pioneer the new age of next-
generation medical devices.
The team at Dfine Bioinnovations Pvt Ltd
exemplifies this spirit, actively innovating and
navigating the challenges to not only withstand
the tides of time but to continuously evolve
and stay relevant. The "Do It In-house"
approach adopted during the development of
FibriTimer reflects a commitment to quality
and innovation, steering away from off-the-
shelf solutions. From an engineering
perspective, this approach presents a daunting
task, involving numerous iterations to realize
the envisioned product.
Careful planning, thorough selection of
components, down to the smallest details like
capacitors or adapters, without compromising
on quality, have resulted in a product that
stands at least 30% more cost-effective than
imported models. This, Mr Asfer asserts, is the
power of self-belief – the power of the right
individuals coming together to achieve what
may seem impossible.
DBI Invites You!
We are proud to par cipate in MEDICAL FAIR INDIA: India's
no. 1 exhibi on and conference for healthcare, which acts
as a pla orm where connec ons are made and business
rela onships are nurtured.
Please visit this exci ng event held at Bombay Exhibi on
Center, Mumbai during 13-15 March 2023. Do mark our stall
G65 (CliniLab India) and visit our stall to know our products,
offerings and solu ons for clinical labs across India.
BIG par cipa on from over 20 countries, MEDICAL FAIR
INDIA provides an opportunity and awareness on the trends
in Medical Device and IVD industry.
Find diverse solu ons to your diverse healthcare needs and
Explore how the latest digital technologies and new
approaches shaping healthcare.
Hoping to meet you in person at our stall!
Team DBI
Bangalore.
#medicafair #pathologist #meddevice Associa on of Indian
Medical Device Industry (AIMED) CPDMED TBI Medical
IISc
Fair India Startup India Startup Karnataka YourStory Media
#ivd
Visit our website, and
www.operonbiotech.com
www.dfinebio.in, for the latest updates and product
offerings.
We are open to exchange ideas and business possibili es via
email at ceo@dfinebio.in
Stay connected with us on our social media network to
follow our work.
18.
19. Stay in touch.
Subscribe to Insightscare and
get the magazine in print, & digital on
www.insightscare.in
Corporate Office
Insights Success Media Tech LLC
Survey No.133/134, Brand Square,
Office No. 512, Kunjir Chowk, Pimple
Saudagar, Pune, Maharashtra 411027
Phone - 7410033802, 8956487823
Email: info@insightscare.in
For Subscription : www.insightscare.in
Cheque should be drawn in favor of :
INSIGHTS SUCCESS MEDIA TECH LLC
www.insightscare.in
20. Empowering Healthcare Transforma on
he next-generation medical technologies are
Tdesigned to improve diagnosis, treatment, and
patient monitoring, leading to better healthcare
outcomes. Advanced medical technologies often enable
minimally invasive procedures, reducing the need for
traditional surgeries. Combining world-class expertise with
digital technologies, MGM Healthcare works together to
ensure successful outcomes for kidney transplants. MGM
provides cutting-edge transplant procedures, which are
supported by a team of cardiologists, cardiac surgeons, and
critical care specialists, with end-stage heart and lung
disease.
Furthermore, MGM prioritizes key strategies that intend to
invest in advanced medical technology and infrastructure,
improving cutting-edge healthcare services. This makes
Insights Care India interview Mr. Harish Manian,
Group CEO, to know more about the modernized
diagnostic equipment and how it all began.
Below are the highlights of the interview:
Kindly tell us the source of inspiration. What led you to
venture into the transplant operations and industry?
Making a significant and positive difference in people's
lives serves as the main source of inspiration for MGM
Healthcare. We are convinced that medical advances have
the potential to transform healthcare and improve the well-
being of individuals and communities. Investing in organ
transplants fits in perfectly with this vision.
Several important factors prompted us to investigate and
invest in the transplant sector. We recognized the enormous
need for organ transplantation around the world, as well as
the life-changing potential it has for patients suffering from
end-stage organ failure. The scarcity of organ donors,
combined with growing waiting lists, prompted us to take
proactive steps to address this pressing healthcare issue.
Our commitment to making a positive impact, addressing
the growing need for organ transplantation, leveraging
advancements in medical science, and providing patient-
centric care, and the unwavering support of our exceptional
team inspired us to begin the organ transplant program at
MGM Healthcare.
Please brief us about the need for transplants in
healthcare. Why is it considered to be of importance
today?
Transplants play an important role in healthcare by
providing a new life to people with organ failure or severe
organ damage. When traditional medical interventions fail
to provide a viable solution, the need for transplants arises.
Organ transplants, such as heart, liver, kidney, and lung
transplants, are critical for patients suffering from end-stage
organ failure because they allow them to regain their health
and quality of life. These procedures have the potential to
significantly extend and improve the lives of patients who
would otherwise face a limited lifespan or rely on
ineffective medical devices or treatments.
Medical science and technology advancements have
increased the success rates of transplant procedures, making
them a viable option for more patients. This has resulted in
a greater understanding and acceptance of transplants as a
standard treatment option for organ failure. The rising
prevalence of chronic diseases such as diabetes,
cardiovascular disease, liver disease and kidney disease has
increased the demand for organ transplants. Organ
availability, whether from deceased donors or living donors,
has become critical in meeting this demand and saving
lives. Transplants have an impact on the entire healthcare
system, not just individual patients. Successful transplant
outcomes reduce the need for long-term, expensive
treatments while also improving overall healthcare
outcomes, making it an important treatment option.
Brief us about your company and shed some light on
your operations in leading the hospital/center.
MGM Healthcare is a well-known healthcare organization
dedicated to providing exceptional medical services and
India's Most Reliable Healthcare Solu on Providers 2024
March 2024 www.insightscare.in
18
21. We combine cu ng-edge
medical treatments with a
pa ent-centered approach to
ensure that our pa ents receive
the best care and support
possible throughout their
healthcare journey.
Mr. Harish Manian
Group CEO
MGM Healthcare
setting the standard for patient care in the industry. As a
leading hospital, we prioritize our patients' health and well-
being above all else. Our dedication to excellence is
reflected in our cutting-edge technology, state-of-the-art
facilities, and highly skilled medical professionals.
We provide a wide range of medical services in a variety of
specialties, including cardiology, neurology, oncology,
orthopedics, and others. Our experienced and
compassionate doctors, nurses, and support staff work
tirelessly to provide personalized care that is tailored to the
specific needs of each patient. We combine cutting-edge
medical treatments with a patient-centered approach to
ensure that our patients receive the best care and support
possible throughout their healthcare journey.
Can you elaborate upon the core values on which the
center is built and what is its mission?
Our core values serve as the foundation for our facility. We
prioritize excellence in healthcare delivery, putting our
patients' needs and well-being at the center of everything
we do. Our mission is to improve the health and lives of
people in our community by providing compassionate and
personalized care, utilizing advanced medical technologies
and expertise. We are dedicated to upholding the highest
levels of professionalism, integrity, and ethical behavior for
our healthcare professionals, while also fostering a
supportive and collaborative environment. Our core values
of compassion, innovation, integrity, and teamwork
motivate us to strive for excellence in healthcare and make
a difference in the lives of those we serve.
What specific endeavors is center at present? Why do
you find those essential?
The New Dawn of a 'Health-caring' Movement
MGM Healthcare's current initiatives revolve around
advancing the 'Health-caring' movement, which includes a
number of critical initiatives. To improve patient care and
experience, we have implemented cutting-edge technology
www.insightscare.in
March 2024 19
22. and infrastructure. This includes the incorporation of
electronic health records, telemedicine services, and remote
monitoring capabilities, allowing us to provide our patients
with personalized and accessible healthcare. These
technological advancements are critical for increasing
efficiency, reducing medical errors, and facilitating
seamless communication between healthcare providers and
patients.
We are concentrating our efforts on preventive healthcare
and wellness programs. Proactive measures, we believe, are
critical in promoting a healthier society and reducing the
burden on the healthcare system. To encourage early
detection and management of diseases, we have established
comprehensive health screening programs, health education
initiatives, and preventive care clinics. By emphasizing
preventive care, we hope to empower people to take charge
of their health and prevent illnesses from progressing,
resulting in better health outcomes and a higher quality of
life.
These initiatives are critical for MGM Healthcare because
they align with our vision of providing our patients with
exceptional healthcare services. We can improve the
efficiency and effectiveness of our care delivery by
embracing technology and innovation. Furthermore,
prioritizing preventive healthcare allows us to shift the
emphasis away from reactive treatments and toward
proactive health management, which has long-term benefits
for both individuals and society as a whole. We are
committed to driving positive change in the healthcare
landscape and fostering a 'Health-caring' movement that
prioritizes the well-being of our patients and the community
through these endeavors.
What are some of the challenges the center faces when
conducting operations and how do they turn them into
growth opportunities?
MGM Healthcare addresses challenges such as managing
rising demand and staying up-to-date on medical advances
by investing in infrastructure, recruiting skilled
professionals, forming partnerships, and embracing cutting-
edge technologies. This allows us to provide better
healthcare services, expand our patient base, and maintain
our position as a leading healthcare provider by
transforming these challenges into growth opportunities.
We recognize that running a hospital presents its own set of
challenges. One of the major challenges we face is meeting
the growing demand for healthcare services. As the
population grows and medical advances continue, so does
the demand for high-quality healthcare. We have
implemented strategies to expand our infrastructure and
increase our capacity in order to address this challenge and
turn it into a growth opportunity. We have invested in
cutting-edge medical equipment, upgraded our facilities,
and hired more skilled healthcare professionals. We not
only provide better access to healthcare for more patients
by effectively managing growing demand, but we also
position ourselves as a leading healthcare provider,
attracting more patients and contributing to our overall
growth.
What advice would you give budding enthusiasts who
want to venture into the sector?
We encourage aspiring healthcare professionals to pursue a
solid educational foundation. Obtaining relevant degrees
and certifications in fields such as medicine, nursing,
pharmacy, or public health is one example. Building a solid
knowledge base will not only provide individuals with a
deeper understanding of the industry, but will also equip
them with the necessary skills to contribute effectively.
How do you envision scaling the centre's services and
operations in 2024 and beyond?
MGM Healthcare will prioritize several key strategies. We
intend to invest in advanced medical technology and
infrastructure in order to improve our capabilities and
provide cutting-edge healthcare services. This includes
modernizing our diagnostic equipment, expanding our
surgical facilities, and implementing cutting-edge treatment
methods. We can attract more patients and provide cutting-
edge treatments if we remain at the forefront of medical
advancements.
We aim to expand our reach and accessibility by
establishing more units domestically allowing us to broaden
our service offerings and extend our geographical footprint.
Additionally, we will leverage telemedicine and digital
healthcare solutions to reach patients in remote areas and
provide virtual consultations and follow-ups.
Overall, our goal is to expand our reach and provide quality
healthcare to a larger group not only in our region but also
globally. By investing in technology, forging partnerships,
and embracing digital healthcare, we are confident in our
ability to scale our services and operations effectively,
providing high-quality and patient-centric care and beyond.
March 2024 www.insightscare.in
20
23.
24. ndia’s healthcare sector is at a crossroads. The COVID-19
Ipandemic has exposed the vulnerabilities of the healthcare
system, while also highlighting the potential for growth
and innovation. The sector is now facing unprecedented
challenges, including a shortage of healthcare professionals, a
lack of infrastructure, and rising healthcare costs. However,
these challenges also present opportunities for the sector to
adapt and grow.
This article highlights the various challenges faced by the
Indian healthcare sector, the innovative solutions being
proposed and the promising growth opportunities ahead.
It is fascinating to see how the sector transforms crisis into an
opportunity for a healthier, more resilient healthcare system.
Challenges facing India’s Healthcare Sector
The COVID-19 pandemic has highlighted the challenges facing
India’s healthcare sector. The country has a shortage of
healthcare professionals. This shortage is particularly severe in
rural areas.
Infrastructure is another challenge facing the sector. This
shortage of infrastructure has been exacerbated by the pan-
demic, with hospitals in some cities reaching capacity.
Rising healthcare costs are also a challenge. According to a
report by the World Health Organization, out-of-pocket
expenditure on healthcare in India is as high as 62.4%, one of
the highest in the world. This high out-of-pocket expenditure
can push millions of people into poverty each year.
March 2024 www.insightscare.in
From Crisis to Opportunity
22
HowIndia’s
Healthcare Sector
is Adapting to Change
26. -Nisha Mehra
Innovative Solutions
Despite these challenges, the healthcare sector is adapting
to change, with innovative solutions being developed.
Telemedicine is one such solution, allowing patients to
consult with doctors remotely. This is particularly important
in rural areas, where access to healthcare is limited.
Another innovative solution is the use of artificial
intelligence (AI) in healthcare. AI can be used for early
disease detection, diagnosis, and treatment. For example,
AI-powered tools can analyse medical images to detect
diseases such as cancer and diabetes. AI can also be used to
predict disease outbreaks, allowing healthcare providers to
prepare for pandemics.
The private sector is also playing a role in driving change in
the healthcare sector. Private hospitals and clinics are
investing in infrastructure and technology to improve
healthcare delivery. They are also partnering with the
government to provide healthcare services in rural areas.
Opportunities Ahead
The Indian healthcare sector is teeming with potential for
growth and investment, thanks to several factors high-
lighted in the provided sources. Here are the key opportuni-
ties:
Government Investments: The Indian government’s
substantial spending on healthcare infrastructure and
initiatives, such as the National Health Mission and
Ayushman Bharat Yojana, is generating significant growth
prospects in the sector.
Private Sector Investments: Private investors are actively
pouring money into areas like diagnostics, hospital chains,
and health tech startups, thereby accelerating the healthcare
sector’s growth.
Rising Demand for Healthcare Services: A growing and
aging Indian population, coupled with a greater emphasis
on preventive healthcare, is driving up the demand for
healthcare services, paving the way for expansion.
Digital Health Technology: The integration of digital
health technology is transforming healthcare services,
making them more accessible, cost-effective, and efficient,
thereby contributing significantly to the sector’s growth.
Pharmaceutical Industry: India’s pharmaceutical industry,
the third largest globally by volume, is poised for continu-
ous growth due to increasing demand for generic drugs and
expanding exports, providing substantial expansion
opportunities.
Investment Opportunities: The Indian healthcare sector
presents a vast array of investment opportunities.
Demographic Trends: India’s demographic shifts, such as
rising life expectancy, an aging population, and a growing
middle-class segment, offer significant growth potential in
the healthcare sector.
Technological Advancements: The incorporation of
technology, such as telemedicine and digital solutions, is
enhancing healthcare services’ accessibility, quality, and
affordability, creating new avenues for investment and
development.
Private Capital Inflows: Private capital investments in
Indian healthcare are on the rise, with notable deals and
attractive returns for investors, indicating strong growth and
profitability potential in the sector.
These opportunities underscore the immense potential for
growth, innovation, and investment in India’s healthcare
sector, making it one of the most promising sectors in the
Indian economy.
Conclusion
India’s healthcare sector is facing significant challenges, but
it is also adapting to change. Telemedicine, AI, and private
sector investment are just some of the innovative solutions
being developed. The government is also playing a crucial
role in driving change, with a focus on primary healthcare
and digital innovation.
The COVID-19 pandemic has shown us that healthcare is
not just a sector, but a vital public service. The healthcare
sector must be strengthened to ensure that it is equipped to
handle future pandemics and provide quality healthcare to
all. The journey from crisis to opportunity in India’s
healthcare sector is a long one, but it is a journey that must
be taken.
March 2024 www.insightscare.in
24
27.
28. Founded by Dheeraj Jain, the brand 'Redcliffe
Labs' was coined in the year 2021 when it ventured
into routine diagnostics services with the foundation
pillar to bring affordable & high-quality diagnostic services
with ease of booking and home collection convenience,
using the most advanced technology and processes, to
people across the Indian subcontinent. Offering more than
3600+ tests for all age groups covering all major diseases
with accurate results and fast turnaround time, Redcliffe
Labs aims to revolutionize the healthcare industry in India.
Before that, it operated under the brand name Redcliffe
Lifesciences, which was started in 2018 with a focus on
specialized testing in reproductive care, oncology, rare
diseases, and research. Redcliffe Labs' expansion into
routine diagnostics services marked a significant milestone
in its journey to provide comprehensive healthcare
solutions to a broader audience.
Redcliffe Labs services are available in 220+ cities across
India through a wide network of on-ground phlebotomists
fleet, 80+ labs, and 2000+ collection centers. All labs and
collection centers follow the highest quality standards from
day one to provide affordable yet high-end quality
diagnostic services to customers.
With a track record of successfully serving 4M+ patients to
date, Redcliffe Labs envisions becoming the most trusted
and affordable diagnostics platform for Bharat, empowering
health and impacting lives positively.
Technological Innovations and Quality Initiatives
In 2023, Redcliffe Labs made significant technological
advancements and innovations aimed at improving the
quality of services and enhancing the overall customer
experience. Some of these developments include:
Ÿ Clinical Decision Support (CDS) System: Redcliffe
Labs introduced the 'AI-based' Abbott AlinIQ Clinical
Decision Support (CDS) System, making it the first
diagnostic provider in India to adopt such a
transformative technology. The CDS system utilizes
advanced data interpretation technology to deliver
patient-specific content and intelligent insights. It offers
supportive guidance and protocol reinforcement to
improve patient care by enhancing clinical management.
This system is clinician-driven and provides customized
Transforming Healthcare with Affordable
& High-Quality Diagnostic Services
March 2024 www.insightscare.in
26
29. clinical insights based on patient demographics,
historical data, and clinical notes. The AI-enabled CDS
algorithm automates the decision-making process for
individual patient cases, reflecting scientific
interpretations driven by clinical recommendations.
Ÿ Implementation of Six Sigma Processes: Redcliffe Labs,
under the guidance of Dr. Sohini Sengupta, its Medical
Director, has implemented Six Sigma processes to
ensure high-quality and accurate test results. Six Sigma
is a data-driven process improvement methodology that
aims to achieve operational excellence by minimizing
errors and defects in processes. By following Six Sigma
principles, Redcliffe Labs aims to achieve 'world-class'
performance, with a focus on reducing the Defects Per
Million Opportunities (DPMO) metric to less than 3.4.
This approach is particularly beneficial in a high-
volume clinical laboratory setting, where thousands of
test results are generated daily, and adherence to quality
specifications is critical.
These innovations demonstrate Redcliffe Labs' commitment
to leveraging technology and adopting best practices to
deliver superior healthcare services and improve patient
outcomes. Through the implementation of advanced
systems like the CDS and adherence to quality
improvement methodologies like Six Sigma, Redcliffe Labs
continues to set new standards in the healthcare and health
tech industry in India.
Driving Change
Dheeraj embarked on a mission in 2017 to revolutionize
healthcare in India by providing affordable, accessible, and
advanced diagnostic services for a Healthier Bharat. His
journey towards this goal began with a strong background
in management technology consulting in London, followed
by nine years of valuable experience at Nokia, where he
gained insights across various functions. His MBA from
Cass Business School further honed his skills and
knowledge.
In 2011, Dheeraj transitioned from Nokia to the leveraged
buyout market, where he played a significant role in Indian
mergers and acquisitions. Returning to India, he co-founded
successful startups like Candes and The Man Company,
with a focus on impactful ventures such as PeeSafe for
women's health.
Recognized as one of the most prolific angel investors,
With ini a ves such as
online campaigns and offline
camps, Redcliffe Labs has
successfully encouraged people to
priori ze their health and undergo
regular health checkups.
‘‘ ‘
‘
Dheeraj Jain
Founder
Redcliffe Labs
India's Most Reliable Healthcare Solu on Providers 2024
www.insightscare.in
March 2024 27
30. Dheeraj continued to foster innovation in the startup
ecosystem. In 2017, his vision culminated in the founding
of Redcliffe Labs, a platform dedicated to providing
affordable and technologically advanced diagnostics to
reshape healthcare in India.
With Dheeraj's vision, the unwavering dedication of
stakeholders, and the commitment of co-founders, Redcliffe
Labs emerged as a beacon of hope, promising a healthier
future for the nation. Dheeraj's journey continues to be
driven by a passion for creating impactful change in
healthcare and improving the lives of people across India.
Impact on India's Healthcare Landscape
Redcliffe Labs has been instrumental in improving the
healthcare landscape of India by focusing on four key
pillars: Quality, Convenience, Affordability, and
Accessibility. In a country where nearly 5.8 million people
die due to Non-Communicable Diseases (NCDs) every
year, Redcliffe Labs has played a crucial role in raising
awareness about preventive health checkups and
empowering individuals to make informed decisions about
their health.
With initiatives such as online campaigns and offline
camps, Redcliffe Labs has successfully encouraged people
to prioritize their health and undergo regular health
checkups. By providing convenient access to high-quality
diagnostic services at affordable prices, Redcliffe Labs has
helped individuals identify health risks early, enabling
timely interventions and preventive measures.
Addressing the growing concern of NCDs, including heart
diseases, stroke, lung diseases, cancer, and diabetes,
Redcliffe Labs is dedicated to promoting a Healthier
Bharat. Through its commitment to quality, convenience,
affordability, and accessibility, Redcliffe Labs continues to
make significant strides in improving healthcare outcomes
and enhancing the overall well-being of the Indian
population.
Balancing Quality and Affordability
Redcliffe Labs faces a significant challenge in the
healthcare sector, particularly in diagnostics, regarding the
pricing and quality of health checkups. Variability in pricing
and ensuring accurate reports are crucial for effective
treatment. Addressing these challenges nationwide requires
balancing high standards with affordability. Redcliffe Labs
tackles this through technology integration, omnichannel
streamlining, and unified software for quality analysis. This
approach ensures precision without inflating costs, aiming
to enhance customer experience and healthcare accessibility
across India.
Providing Uninterrupted Services Amidst the Pandemic
Starting services during the pandemic proved advantageous
for Redcliffe Labs, as all team members, including field
personnel like riders and phlebotomists, received tailored
training. Consequently, ensuring safety for both the team
and customers, whether during or after the pandemic, isn't a
challenge. Redcliffe Labs remains steadfast in delivering
uninterrupted services, reaffirming its commitment to
customer care and operational excellence.
Dheeraj embarked on a
mission in 2017 to revolu onize
healthcare in India by providing
affordable, accessible, and
advanced diagnos c services for a
Healthier Bharat.
‘‘ ‘
‘
March 2024 www.insightscare.in
28
31. Democratize Healthcare Across India
Redcliffe Labs has established a widespread presence
across India, spanning over 220 cities with 2000+ collection
centers and 80+ labs. The ambitious goal for 2030 is to
serve 500 million people nationwide. Notably, the company
prioritizes expansion in tier 2 and tier 3 cities, aiming to
bridge healthcare disparities. Even in regions with limited
digital engagement, Redcliffe Labs actively reaches out,
organizing over 1500 health camps weekly, catering to the
healthcare needs of over 2 lakh+ patients. This concerted
effort reflects the company's commitment to making
healthcare accessible to all, irrespective of geographical or
digital barriers.
Empowering Wellness
There is an urgent need to address the high risk of Non-
Communicable Diseases (NCDs) in India, with 1 in every 4
individuals succumbing to NCDs before the age of 70. To
improve India's healthcare scenario, Redcliffe Labs made a
strategic shift towards wellness-focused approaches rather
than solely addressing illness. It actively contributes to this
goal by promoting preventive healthcare checkups and
offering high-quality diagnostics at affordable rates.
A study presented in the UN General Assembly in
September 2023 underscores the economic impact of
Redcliffe Labs' diagnostics in India. The study indicates
that Redcliffe's tests deliver approximately $400 million in
economic savings by offering cost-effective solutions for
preventing cardiovascular disease and diabetes. Specifically,
Redcliffe's tests are found to be up to 8 times more cost-
effective than national treatment coverage for
cardiovascular disease and less than 2/3 the cost of
comparable screening and telemedicine interventions for
diabetes. This highlights the significant contribution of
Redcliffe Labs towards reducing the burden of NCDs and
promoting a healthier Bharat.
www.insightscare.in
March 2024 29
33. ndia’s healthcare sector has been making significant
Istrides in recent years, driven by a combination of
factors such as government initiatives, private sector
investments, and technological advancements. The sector’s
growth has not only led to improved healthcare services
within the country but has also created a ripple effect, with
India’s healthcare solutions making a global impact beyond
its borders.
This article explores how India’s healthcare solutions are
making a mark on the global stage and the potential for
further growth and impact.
Government Initiatives Driving Global Impact
The Indian government’s initiatives to strengthen the
healthcare sector have played a crucial role in driving the
sector’s growth and global impact. The National Health
Mission, Ayushman Bharat Yojana, and other government
programs have led to improved healthcare infrastructure,
increased access to healthcare services, and a focus on
preventive healthcare. These initiatives have not only
improved healthcare services within the country but have
also created a model for other developing countries to
emulate.
India’s healthcare solutions, such as telemedicine, mobile
health, and electronic health records, have gained
international recognition for their potential to improve
healthcare access and delivery in remote and underserved
areas. The Indian government’s emphasis on digital health
has led to the creation of a robust digital health
Beyond Borders
India’s
Healthcare
Solutions Making a
Global Impact
www.insightscare.in
March 2024 31
34. infrastructure, which has enabled the development and
deployment of innovative healthcare solutions beyond the
country’s borders.
Private Sector Investments Fueling Global Growth
Private sector investments in India’s healthcare sector have
been a significant driver of growth and innovation. Private
investors, including venture capitalists and private equity
firms, have been actively investing in areas such as
diagnostics, hospital chains, and health tech startups. These
investments have led to the development of innovative
healthcare solutions that have the potential to make a global
impact.
Increasing Demand for Healthcare Services Driving
Global Impact
The growing and aging Indian population, coupled with a
rising awareness of preventive healthcare, has led to an
increased demand for healthcare services. This demand has
created opportunities for the growth and expansion of
healthcare services beyond the country’s borders.
Indian healthcare providers, including hospitals and clinics,
have been expanding their operations beyond the country’s
borders, catering to the global demand for healthcare
services. These providers have been leveraging their
expertise in areas such as telemedicine, medical tourism,
and remote patient monitoring to make a global impact.
Digital Health Technology Driving Global Impact
The adoption of digital health technology is revolutionizing
healthcare services, making them more accessible,
affordable, and efficient. India’s digital health infrastructure
has enabled the development and deployment of innovative
healthcare solutions beyond the country’s borders.
For instance, Indian health tech startups have been
developing innovative solutions in areas such as
telemedicine, artificial intelligence, and machine learning.
These solutions have the potential to transform healthcare
delivery, making it more accessible, affordable, and
efficient. The global demand for these solutions has led to
Indian health tech startups expanding their operations
beyond the country’s borders, making a mark on the global
stage.
Medical Devices Market Driving Global Impact
The Indian medical devices market is projected to grow
significantly, presenting lucrative opportunities for
investment and innovation. The global demand for medical
devices, coupled with the Indian government’s initiatives to
promote the medical devices sector, has led to an increase
in the production and export of medical devices from India.
Indian medical device manufacturers have been leveraging
their expertise in areas such as manufacturing, engineering,
and design to develop innovative medical devices that meet
global standards. These manufacturers have been expanding
their operations beyond the country’s borders, catering to
the global demand for medical devices.
Pharmaceutical Industry Driving Global Impact
India’s pharmaceutical industry, the third largest in the
world by volume, is expected to continue growing due to
increasing demand for generic drugs and growing exports,
offering substantial opportunities for expansion. The global
demand for generic drugs, coupled with the Indian
government’s initiatives to promote the pharmaceutical
sector, has led to an increase in the production and export of
pharmaceuticals from India.
Indian pharmaceutical companies have been leveraging
their expertise in areas such as manufacturing, research, and
development to develop innovative pharmaceutical
solutions that meet global standards. These companies have
been expanding their operations beyond the country’s
borders, catering to the global demand for pharmaceuticals.
Conclusion
India's healthcare solutions are exerting a global influence,
driven by the convergence of government initiatives,
private sector investments, and technological
advancements. The potential for further growth and impact
is significant, with opportunities in areas such as digital
health technology, medical devices, and pharmaceuticals.
The Indian healthcare sector’s growth and global impact are
a testament to the country’s potential as a global leader in
healthcare solutions. The sector’s continued growth and
success will not only benefit the Indian economy but will
also contribute to improving healthcare services globally.
-Nisha Mehra
March 2024 www.insightscare.in
32
